Pathologic Alterations of Nerves

Peripheral Neuropathy

Volumn 1, Issue , 2005, Pages 733-829

  Dyck, Peter J ^a   Dyck, P James B ^b   Engelstad, JaNean ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32644443079     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50035-1     Document Type: Chapter

References (165)

1. Aguayo A.J., Attiwell M., Trecarten J., et al. Abnormal myelination in transplanted Trembler mouse Schwann cells. Nature 1977, 265:73.
2. Aitken J.T., Thomas P.K. Retrograde changes in fiber size following nerve section. J. Anat. 1962, 96:121.
3. Anders E., Dietz D.D., Bagnell C.R., et al. Morphological, pharmacokinetic, and hematological studies of lead-exposed pigeons. Environ. Res. 1982, 28:344.
4. Asbury A.K. Renaut bodies: a forgotten endoneurial structure. J. Neuropathol. Exp. Neurol. 1973, 32:334.
5. Asbury A.K., Aldredge H., Hershberg R., Fisher C.M. Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 1970, 93:555.
6. Asbury A.K., Arnason B.G., Adams R.D. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine 1969, 48:173.
7. Barltrop D., Barrett A.J., Dingle J.T. Subcellular distribution of lead in the rat. J. Lab. Clin. Med. 1971, 77:705.
8. Barnes J.M., Denz F.W. Experimental demyelination and organophosphorus compounds. J. Pathol. Bacteriol. 1953, 65:597.
9. Barton J.C., Conrad M.E., Harrison L., Nuby S. Effects of calcium on the absorption and retention of lead. J. Lab. Clin. Med. 1978, 91:366.
10. Beckman S.S. Intranuclear inclusion bodies in the kidney and liver caused by lead poisoning. Bull. Johns Hopkins Hosp. 1936, 58:384.
11. Benstead T.J., Dyck P.J., Sangalang V. Inner perineurial cell vulnerability in ischemia. Brain Res. 1989, 489:177.
12. Besinger U.A., Toyka K.V., Anzil A.P., et al. Myeloma neuropathy: passive transfer from man to mouse. Science 1981, 213:1027.
13. Bignami A., Dahl D., Nguyen B.T., Crosby C.J. The fate of axonal debris in Wallerian degeneration of rat optic and sciatic nerves: electron microscopy and immunofluorescence studies with neurofilament antisera. J. Neuropathol. Exp. Neurol. 1981, 40:537.
14. Bischoff A., Fierz U., Regli F., Ulrich J. Peripheral neurological disorders in Fabry's disease (angiokeratoma corporis diffusum universale): clinical and electron microscopic findings in a case [in German]. Klin. Wochenschr. 1968, 46:666.
15. Bourque C.N., Anderson B.A., Martin del Campo C., Sima A.A. Sensorimotor perineuritis-an autoimmune disease? Can. J. Neurol. Sci. 1985, 12:129.
16. Boyd I.A., Davey M.R. Composition of Peripheral Nerves 1968, E & S Livingston, Edinburgh.
17. Bradley W.G., Jenkison M. Abnormalities of peripheral nerves in murine muscular dystrophy. J. Neurol. Sci. 1973, 18:227.
18. Bunge R.P., Bunge M.B., Williams A.K., Wartels L.K. Does the dystrophic mouse nerve lesion result from an extracellular matrix abnormality?. Disorders of the Motor Unit 1982, 23. Wiley, New York. D.L. Schotland (Ed.).
19. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 1968, 18:841.
20. Cavanagh J.B. The toxic effects of tri-ortho-cresyl phosphate on the nervous system: an experimental study in lens. J. Neurol. Neurosurg. Psychiatry 1954, 17:163.
21. Chou S.M., Hartmann H.A. Axonal lesions and waltzing syndrome after IDPN administration in rats. Acta Neuropathol. (Berl.) 1964, 3:428.
22. Chou S.M., Hartmann H.A. Electron microscopy of focal neuroaxonal lesions produced by beta-beta-iminodipropionitrile (IDPN) in rats. Acta Neuropathol. (Berl.) 1965, 4:590.
23. Clark A.W., Griffin J.W., Price D.L. The axonal pathology in chronic IDPN intoxication. J. Neuropathol. Exp. Neurol. 1980, 39:42.
24. Cragg G.B., Thomas P.K. Changes in conduction velocity and fibre size proximal to peripheral nerve lesions. J. Physiol. (Lond.) 1961, 157:315.
25. Dayan A.D., Graveson G.S., Robinson P.K., Woodhouse M.A. Globular neuropathy: a disorder of axons and Schwann cells. J. Neurol. Neurosurg. Psychiatry 1968, 31:552.
26. Denny-Brown D., Brenner C. Paralysis of nerve induced by direct pressure and by tourniquet. Arch. Neurol. Psychiatry 1944, 51:1.
27. Doinikow B. Beitrage zur histologie und histopathologie der peripheren nerven. Histol. Histopathol. Arb. 1911, 4:445.
28. Donaghy M., Brett E.M., Ormerod I.E., et al. Giant axonal neuropathy: observations on a further patient. J. Neurol. Neurosurg. Psychiatry 1988, 51:991.
29. Donaghy M., King R.H., Thomas P.K., Workman J.M. Abnormalities of the axonal cytoskeleton in giant axonal neuropathy. J. Neurocytol. 1988, 17:197.
30. Dreyfus R.M., Hakim S., Adams R.D. Diabetic ophthalmoplegia: report of a case with postmortem study and comments on vascular supply of human oculomotor nerve. Arch. Neurol. Psychiatry 1957, 77:337.
31. Dyck P.J. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988, 11:21.
32. Dyck P.J. Experimental hypertrophic neuropathy: pathogenesis of onion-bulb formations produced by repeated tourniquet applications. Arch. Neurol. 1969, 21:73.
33. Dyck P.J. Is there an axonal variety of GBS?. Neurology 1993, 43:1277.
34. Dyck P.J., Conn D.L., Okazaki H. Necrotizing angiopathic neuropathy: three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin. Proc. 1972, 47:461.
35. Dyck P.J., Ellefson R.D., Lais A.C., et al. Histologic and lipid studies of sural nerves in inherited hypertrophic neuropathy: preliminary report of a lipid abnormality in nerve and liver in Dejerine-Sottas disease. Mayo Clin. Proc. 1970, 45:286.
36. Dyck P.J., Ellefson R.D., Yao J.K., Herbert P.N. Adult-onset of Tangier disease: 1. Morphometric and pathologic studies suggesting delayed degradation of neutral lipids after fiber degeneration. J. Neuropathol. Exp. Neurol. 1978, 37:119.
37. Dyck P.J., Giannini C., Lais A. Pathologic alterations of nerves. Peripheral Neuropathy 1993, 514. W. B. Saunders, Philadelphia. 3rd ed. P.J. Dyck, P.K. Thomas, J.W. Griffin (Eds.).
38. Dyck P.J., Johnson W.J., Lambert E.H., O'Brien P.C. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin. Proc. 1971, 46:400.
39. Dyck P.J., Karnes J., Sparks M., Low P.A. The morphometric composition of myelinated fibers by nerve, level, and species related to nerve microenvironment and ischemia. Electroencephalogr. Clin. Neurophysiol. Suppl. 1982, 36:39.
40. Dyck P.J., Kawamura Y., Low P.A., et al. The number and sizes of reconstructed peripheral autonomic, sensory and motor neurons in a case of dysautonomia. J. Neuropathol. Exp. Neurol. 1978, 27:741.
41. Dyck P.J., Kratz K.M., Lehman K.A., et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991, 41:799.
42. Dyck P.J., Lais A.C. Electron microscopy of teased nerve fibers: method permitting examination of repeating structures of same fiber. Brain Res. 1970, 23:418.
43. Dyck P.J., Lais A.C. Evidence for segmental demyelination secondary to axonal degeneration in Friedreich's ataxia. Clinical Studies in Myology 1973, 253. Excerpta Medica, Amsterdam. B.A. Kakulas (Ed.).
44. Dyck P.J., Lais A.C., Giannini C., Engelstad J.K. Structural alterations of nerve during cuff compression. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:9828.
45. Dyck P.J., Lais A.C., Hansen S.M., et al. Technique assessment of demyelination from endoneurial injection. Exp. Neurol. 1982, 77:359.
46. Dyck P.J., Lambert E.H. Dissociated sensation in amyloidosis: compound action potential, quantitative histo-logic and teased fiber, and electron microscopic studies of sural nerve biopsies. Arch. Neurol. 1969, 20:490.
47. Dyck P.J., Lambert E.H. Polyneuropathy associated with hypothyroidism. J. Neuropathol. Exp. Neurol. 1970, 29:631.
48. Dyck P.J., Lambert E.H., Nichols P.C. Quantitative measurement of sensation related to compound action potential and number and sizes of myelinated and unmyeli-nated fibers of sural nerves in health, Friedreich's ataxia, hereditary sensory neuropathy, and tabes dorsalis. Handbook of Electroencephalography and Clinical Neurophysiology 1971, 83. Elsevier, Amsterdam. W.A. Cobb (Ed.).
49. Dyck P.J., Lofgren E.P. Nerve biopsy: choice of nerve, method, symptoms, and usefulness. Med. Clin. North Am. 1968, 52:885.
50. Dyck P.J., Low P.A., Sparks M.F., et al. Effect of serum hyperosmolality on morphometry of healthy human sural nerve. J. Neuropathol. Exp. Neurol. 1980, 39:285.
51. Dyck P.J., NGBRada H., Lais A.C., Karnes J.L. Permanent axotomy: a model of chronic neuronal degeneration preceded by axonal atrophy, myelin remodeling and degeneration. Peripheral Neuropathy 1984, 666. W. B. Saunders, Philadelphia. 2nd ed. P.J. Dyck, P.K. Thomas, E.H. Lambert, R.P. Bunge (Eds.).
52. Dyck P.J., O'Brien P.C Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care 1989, 12:649.
53. Dyck P.J., O'Brien P.C., Ohnishi A. Lead neuropathy: II. Random distribution of segmental demyelination among "old internodes" of myelinated fibers. J. Neuropathol. Exp. Neurol. 1977, 36:570.
54. Dyck P.J.B., Dyck P.J. Chronic inflammatory demyelinating mononeuropathy (CIDM): a focal form of CIDP?. Neurology 2002, 58:A303.
55. Dyck P.J.B., Engelstad J., Norell J., Dyck P.J. Microvasculitis in non-diabetic lumbosacral radiculo-plexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). J. Neuropathol. Exp. Neurol. 2000, 59:525.
56. Dyck P.J.B., Norell J.E., Dyck P.J. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999, 53:2113.
57. Elzholz A. Zur Kenntnis der Veranderungen im centralen Strumpf ladierter gemischter Nerven. Jahrb. Psychiatr. 1898, 17:323.
58. Erlanger J., Gasser H.S. Electrical Signs of Nervous Activity 1937, University of Pennsylvania Press, Philadelphia.
59. Evans M.J., Finean J.B., Woolf A.L. Ultrastructural studies of human cutaneous nerve with special reference to lamellated cell inclusions and vacuole-containing cells. J. Clin. Pathol. 1965, 18:188.
60. Feasby T.E., Hahn A.F., Gilbert J.J. Passive transfer of demyelinating activity in Guillain-Barre polyneuropathy. Neurology (N. Y.) 1980, 30:363.
61. Fullerton P. The relation between fibre diameter and internodal length in chronic neuropathy. J. Physiol. (Lond.) 1965, 178:26.
62. Gerber G.B., Leonard A., Jacquet P. Toxicity, mutagenicity and teratogenicity of lead. Mutat. Res. 1980, 76:115.
63. Gombault A. Contribution a ľetude anatomique de la nevrite parenchymateuse subaigue et chronique: nevrite sementaire peri-axile. Arch. Neurol. (Paris) 1880, 1:11.
64. Gombault A. Sur les lesions de la nevrite alcoolique. C. R. Soc. Biol. (Paris) 1886, 102:439.
65. Gonatas N.K., Evangelista I., Martin J. A generalized disorder of nervous system, skeletal muscle and heart resembling Refsum's disease and Hurler's syndrome. Am. J. Med. 1967, 42:169.
66. Goyer R.A. Lead and the kidney. Curr. Top. Pathol. 1971, 55:147.
67. Goyer R.A., Rhyne B.C. thological effects of lead. Int. Rev. Exp. Pathol. 1973, 12:1.
68. Griffin J.W., Hoffman P.N., Clark A.W., et al. Slow axonal transport of neurofilament proteins: impairment by β, β'-iminodipropionitrile. Science 1978, 202:633.
69. Griffin J.W., Price D.L. Proximal axonopathies induced by toxic chemicals. Experimental and Clinical Neurotoxicology 1980, 161. Williams & Wilkins, Baltimore. P.S. Spencer, H.H. Schaumberg (Eds.).
70. Grundfest H. The effects of hydrostatic pressure upon excitability, the recovery, and the potential sequence of frog nerve. Cold Spring Harb. Symp. Quant. Biol. 1936, 4:179.
71. Gutmann E., Sanders F.K. Recovery of fibre numbers and diameters in the regeneration of peripheral nerves. J. Physiol. (Lond.) 1943, 101:489.
72. Haas L.F., Austad W.I., Bergin J.D. Tangier disease. Brain 1974, 97:351.
73. Hall S.M., Gregson N.A. The in vivo and ultra-structural effects of injection of lysophosphatidylcholine into myelinated peripheral nerve fibers of the adult mouse. J. Cell Sci. 1971, 9:769.
74. Harary I., Berliner J. Electron microscopic examination of lead treated L6 skeletal muscle line cells in culture. J. Environ. Pathol. Toxicol. 1980, 4:305.
75. Haymaker W., Kernohan J.W. The Landry-Guillain-Barre syndrome: clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine 1949, 28:59.
76. Hess K., Eames R., Darveniza P., Gilliatt R.W. Acute ischemic neuropathy in the rabbit. J. Neurol. Sci. 1979, 44:19.
77. Hietanen E., Kilpio J., Narhi M., et al. Biotransformational and neurophysiological changes in rabbits exposed to lead. Arch. Environ. Contam. Toxicol. 1980, 9:337.
78. Hirano A. Aspects of the ultrastructure of amyotrophic lateral sclerosis. Advances in Neurology: Human Motor Neuron Diseases 1982, 75. Raven Press, New York. L.P. Rowland (Ed.).
79. Hoffer J.A., Stein R.B., Gordon T. Differential atrophy of sensory and motor fibers following section of cat peripheral nerves. Brain Res. 1979, 178:347.
80. Hoffman P.N., Lasek R.J. Axonal transport of the cytoskeleton in regenerating motor neurons: constancy and change. Brain Res. 1980, 202:317.
81. Jacquet P., Gerber G.B. Teratogenic effects of lead in the mouse. Biomedicine 1979, 30:223.
82. Johnson P.B., Brendel K., Meezan E. Human diabetic perineurial cell basement membrane thickening. Lab. Invest. 1981, 44:265.
83. Karai I., FGBRumoto K., Horiguchi S. Studies on osmotic fragility of red blood cells determined with a coil planet centrifuge for workers occupationally exposed to lead. Int. Arch. Occup. Environ. Health 1981, 48:273.
84. Karnes J., Robb R., O'Brien P.C., et al. Computerized image recognition for morphometry of nerve attribute of shape of sampled transverse sections of myelinated fibers which best estimates their average diameter. J. Neurol. Sci. 1977, 34:43.
85. Kawamura Y., Dyck P.J. Evidence for three populations by size in L5 spinal ganglion in man. J. Neuropathol. Exp. Neurol. 1978, 37:269.
86. Kawamura Y., Dyck P.J., Shimono M., et al. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1981, 40:667.
87. Kawamura Y., O'Brien P., Okazaki H., Dyck P.J. Lumbar motoneurons of man: II. The number and diameter distribution of large- and intermediate-diameter cytons in "motoneuron columns" of spinal cord of man. J. Neuropathol. Exp. Neurol. 1977, 36:861.
88. Kernohan J.W., Woltman H.W. Periarteritis nodosa: a clinicopathologic study with special reference to the nervous system. Arch. Neurol. 1938, 39:655.
89. Kernohan J.W., Woltman H.W. Amyloid neuritis. Arch. Neurol. Psychiatry 1942, 47:132.
90. Key A., Retzius G. Studien in der Anatomie des Nerven-systems und des Bingegewebes 1876, II. Nordstedt and Soner, Stockholm.
91. King R.H., Llewelyn J.G., Thomas P.K., et al. Diabetic neuropathy: abnormalities of Schwann cell and perineurial basal laminae. Implications for diabetic vasculopathy. Neuropathol. Appl. Neurobiol. 1989, 15:339.
92. Kocen R.S., Lloyd J.K., Lascelles P.T., et al. Familial alpha-lipoprotein deficiency (Tangier disease) with neurological abnormalities. Lancet 1967, 1:1341.
93. Kocen R.S., Thomas P.K. Peripheral nerve involvement in Fabry's disease. Arch. Neurol. 1970, 22:81.
94. Korthals J.K., Gieron M.A., Wisniewski H.M. Nerve regeneration patterns after acute ischemic injury. Neurology 1989, 39:932.
95. Korthals J.K., Korthals M.A., Wisniewski H.M. Peripheral nerve ischemia. Part 2. Accumulation of organelles. Ann. Neurol. 1978, 4:487.
96. Korthals J.K., Wisniewski H.M. Peripheral nerve ischemia. Part 1. Experimental model. J. Neurol. Sci. 1975, 24:65.
97. Krucke W. Erkrankungen der peripheren Nerven. Handbuch der speziellen pathologischen Anatomie und Histologie 1955, 105. Springer-Verlag, Berlin. F. Henke, O. Labarsch, R. Rossle (Eds.).
98. Kummer H., Laissue J., Spiess H., et al. Familial alphalipoproteinemia (Tangier disease) [in German]. Schweiz. Med. Wochenschr. 1968, 98:406.
99. Lampert P.W., Schochet S.S. Demyelination and remyelination in lead neuropathy: electron microscopic studies. J. Neuropathol. Exp. Neurol. 1968, 27:527.
100. Levander O.A., Fisher M., Morris V., Ferretti R.J. Morphology of erythrocytes from vitamin E-deficient lead-poisoned rats. J. Nutr. 1978, 107:1828.
101. Lewis R.A., Sumner A.J., Brown M.J., Asbury A.K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982, 32:958.
102. Low P.A., Baumann W.J., Parthasarathy S. Structure-demyelinating-activity study of lysolecithin analogs in mammalian peripheral nerve. Neurology 1982, 32:A104.
103. Low P.A., Dyck P.J. Increased endoneurial fluid pressure in experimental lead neuropathy. Nature 1977, 269:427.
104. Low P.A., Okazaki H., Dyck P.J. Splanchnic preganglionic neurons in man. I. Morphometry of preganglionic cytons. Acta Neuropathol. (Berl.) 1977, 40:55.
105. Low P.A., Schmelzer J.D., Dyck P.J. Results of endoneurial injection of Guillain-Barre serum in Lewis rats. Mayo Clin. Proc. 1982, 57:360.
106. Lubinska L. Region of transection between preserved and regenerating parts of myelinated nerve fibers. J. Comp. Neurol. 1959, 113:315.
107. Lubinska L. Patterns of wallerian degeneration of myelinated fibres in short and long peripheral stumps and in isolated segments of rat phrenic nerve: interpretation of the role of axoplasmic flow of the trophic factor. Brain Res. 1982, 233:227.
108. Luna L.G. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology 1968, McGraw-Hill, New York. 3rd ed.
109. Madrid R.E., Wisniewski H.M. Axonal degeneration in demyelinating disorders. J. Neurocytol. 1977, 6:103.
110. Moore J.F., Goyer R.A., Wilson M. Lead-induced inclusion bodies: solubility, amino acid content, and relationship to residual acidic nuclear proteins. Lab. Invest. 1973, 29:488.
111. Moore M.R. Diet and lead toxicity. Proc. Nutr. Soc. 1979, 38:243.
112. Myers R.R., Powell H.C., Shapiro H.M., et al. Changes in endoneurial fluid pressure, permeability, and peripheral nerve ultrastructure in experimental lead neuropathy. Ann. Neurol. 1980, 8:392.
113. Mylroie A.A., Moore L., Olyai B., Anderson M. Increased susceptibility to lead toxicity in rats fed semipurified diets. Environ. Res. 1978, 15:57.
114. NGBRada H., Dyck P.J. Microsphere embolization of nerve capillaries and fiber degeneration. Am. J. Pathol. 1984, 115:275.
115. NGBRada H., Dyck P.J. Acute ischemia causes axonal stasis, swelling, attenuation, and secondary demyelination. Ann. Neurol. 1987, 22:311.
116. Ochoa J., Danta G., Fowler T.J., Gilliatt R.W. Nature of the nerve lesion caused by a pneumatic tourniquet. Nature 1971, 233:265.
117. Ochoa J., Fowler T.J., Gilliatt R.W. Anatomical changes in peripheral nerves compressed by a pneumatic tourniquet. J. Anat. 1972, 113:433.
118. Ohnishi A., Dyck P.J. Loss of small peripheral sensory neurons in Fabry disease: histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch. Neurol. 1974, 31:120.
119. Ohta M., Offord K., Dyck P.J. Morphometric evaluation of first sacral ganglia of man. J. Neurol. Sci. 1974, 22:73.
120. Okada E. Ueber Zwiebelartige Gebilde im peripherischen Nerven (Renaut'sche Korperchen) bei einem Fall von Kakke (Beriberi). Tokyo Imperial Univ. Coll. Med. 1903, 6:93.
121. Okazaki H., Campbell R.J. Nervous system. Current Methods of Autopsy Practice 1979, 95. W. B. Saunders, Philadelphia. 2nd ed. J. Ludwig (Ed.).
122. Parry G.J., Brown M.J. Selective fiber vulnerability in acute ischemic neuropathy. Ann. Neurol. 1982, 11:147.
123. Powell H.C., Myers R.R., Lampert P.W. Changes in Schwann cells and vessels in lead neuropathy. Am. J. Pathol. 1982, 109:193.
124. Powell H.C., Ward H.W., Garrett R.S., et al. Glycogen accumulation in the nerves and kidney of chronically diabetic rats: a quantitative electron microscopic study. J. Neuropathol. Exp. Neurol. 1979, 38:114.
125. Prineas J. The pathogenesis of dying-back polyneuropathies: I. An ultrastructural study of experimental tri-ortho-cresyl phosphate intoxication in the cat. J. Neuropathol. Exp. Neurol. 1969, 28:571.
126. Prineas J. The pathogenesis of dying-back polyneuropathies: II. An ultrastructural study of experimental acrylamide intoxication in the cat. J. Neuropathol. Exp. Neurol. 1969, 28:598.
127. Reich F. Uber den zelligen Aufbau der Nervenfaser auf Grund mikrohistichemischer Untersuchungen. J. Psychol. Neurol. 1907, 8:244.
128. Renaut J. Systeme hyalin de soutenement des centres nerveux et de quelques organes des sens. Arch. Physiol. Normale Pathol. 1881, 8:854-860.
129. Renaut M.J. Recherches sur quelques points particuliers de l'histologie des nerfs. I. La gaine lamelleuse et le systeme hyalin intravaginal. Arch. N. Psych. 1881, 8:161-190.
130. Romeis B. Mikroskopische Technik 1948, 15. Leibniz, Munchen.
131. Saida G., Saida K., Saida T., Asbury A.K. Axonal lesions in acute experimental demyelination: sequential teased nerve fiber study. Neurology (N. Y.) 1981, 31:413.
132. Saida T., Saida K., Silberberg D.H., Brown M.J. Transfer of demyelination by intraneural injection of experimental allergic neuritis serum. Nature 1978, 272:639.
133. Schlaepfer W.W., Hasler M.B. The persistence and possible externalization of axonal debris during wallerian degeneration. J. Neuropathol. Exp. Neurol. 1979, 38:242.
134. Schoene W.C., Asbury A.K., Astrom K.E., Masters R. Hereditary sensory neuropathy: a clinical and ultrastructural study. J. Neurol. Sci. 1970, 11:463.
135. Schuchmann J.A. Isolated sural neuropathy: report of two cases. Arch. Phys. Med. Rehabil. 1980, 61:329.
136. Seitelberger F. Neuroaxonal dystrophy: its relation to aging and neurologic diseases. Extrapyramidal Disorders 1986, 391. Elsevier, Amsterdam. P. Vinken, G. Bruyn, H. Klawans (Eds.).
137. Shelton K.R., Egle P.M. The proteins of lead-induced intranuclear inclusion bodies. J. Biol. Chem. 1982, 257:11802.
138. Shimono M., Izumi K., Kuroiwa Y. 3, 3'-Iminodipropionitrile induced centrifugal segmental demyelination and onion bulb formation. J. Neuropathol. Exp. Neurol. 1978, 37:375.
139. Silbergeld E.K., Adler H.S., Costa J.L. Subcellular localization of lead in synaptosomes. Res. Commun. Chem. Pathol. Pharmacol. 1977, 17:715.
140. Silbergeld E.K., Hruska R.E., Miller L.P., Eng N. Effects of lead in vivo and in vitro on GABAergic neuro-chemistry. J. Neurochem. 1980, 34:1712.
141. Silbergeld E.K., Wolinsky J.S., Goldstein G.W. Electron probe microanalysis of isolated brain capillaries poisoned with lead. Brain Res. 1980, 189:369.
142. Sinnreich M., Daube J.R., Klein C.J., Dyck P.J.B. Inflammatory sensory polyradiculopathy. Neurology 2003, 60:A159.
143. Sobel A.E., Yuska H., Kramer B. The biochemical behavior of lead. I. Influence of calcium, phosphorus and vitamin D on lead in blood and bone. J. Biol. Chem. 1940, 132:239.
144. Spencer P.S. The traumatic neuroma and proximal stump. Bull. Hosp. Joint Dis. 1974, 35:85.
145. Spencer P.S., Schaumburg H.H. Central-peripheral distal axonopathy-the pathology of dying-back polyneuropathies. Progress in Neuropathy 1976, 252. Grune & Stratton, New York. H.M. Zimmerman (Ed.).
146. Spencer P.S., Thomas P.K. The examination of isolated nerve fibres by light and electron microscopy, with observations on demyelination proximal to neuromas. Acta Neuropathol. (Berl.) 1970, 16:177.
147. Spencer P.S., Thomas P.K. Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseased axons. J. Neurocytol. 1974, 3:763.
148. Steward V.W., Hitchcock C. Fabry's disease (angiokeratoma corporis diffusum): a report of five cases with pain in the extremities as the chief symptom. Pathol. Eur. 1968, 3:377.
149. Stoll G., Reiners K., Schwendemann G., et al. Normal myelination of regenerating peripheral nerve sprouts despite circulating antibodies to galactocerebroside in rabbits. Ann. Neurol. 1986, 19:189.
150. Stoner G.L., Brosnan C.F., Wisniewski H.M., Bloom B.R. Studies on demyelination by activated lymphocytes in the rabbit eye. I. Effects of a mononuclear cell infiltrate induced by products of activated lymphocytes. J. Immunol. 1977, 118:2094.
151. Terzis J.K., Daniel R.K., Williams H.B., Spencer P.S. Benign fatty tumors of the peripheral nerves. Ann. Plast. Surg. 1978, 1:193.
152. Thomas P.K., Slatford J. Lamellar bodies in the cytoplasm of Schwann cells. Proc. Anat. Soc. Great Britain Ireland 1964, 98:691.
153. Thomas P.K., Young J.Z. Internode lengths in the nerves of fishes. J. Anat. 1968, 82:336.
154. Tomonaga M., Sluga E. Zur UltrastrGBRtur der (pi)-granula. Acta Neuropathol. (Berl.) 1970, 15:56.
155. Vallat J.M., Gil R., Leboutet M.J., et al. Congenital hypo- and hypermyelination neuropathy: two cases. Acta Neuropathol. (Berl.) 1987, 74:197.
156. Verschaeve L., Driesen M., Kirsch-Volders M., et al. Chromosome distribution studies after inorganic lead exposure. Hum. Genet. 1979, 49:147.
157. Walton I., Buckley I.K. The lead-poisoned cell: a fine structural study using cultured kidney cells. Exp. Mol. Pathol. 1977, 27:167.
158. Weber R.B., Daroff R.B., Mackey E.A. Pathology of oculomotor nerve palsy in diabetics. Neurology 1970, 20:835.
159. Weller R.O., Das Gupta T.K. Experimental hypertrophic neuropathy: an electron microscope study. J. Neurol. Neurosurg. Psychiatry 1968, 31:34.
160. Williams I.R., Jefferson D., Gilliatt R.W. Acute nerve compression during limb ischaemia-an experimental study. J. Neurol. Sci. 1980, 46:199.
161. 210Pb entry into the endoneurium. Brain Res. 1981, 225:67.
162. Windebank A.J., McCall J.T., Hunder H.G., Dyck P.J. The endoneurial content of lead related to the onset and severity of segmental demyelination. J. Neuropathol. Exp. Neurol. 1980, 39:692.
163. Wisniewski H.M., Bloom B.R. Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction. J. Exp. Med. 1975, 141:346.
164. Wohlfart G. Degenerative and regenerative axonal changes in the ventral horns, brain stem, and cerebral cortex in amyotrophic lateral sclerosis. Acta Univ. Lund. (Ner Ser. 2) 1959, 56:1.
165. Yoshikawa H., Dyck P.J., Poduslo J.F., Giannini C. Polyglucosan body axonal enlargement increases myelin spiral length but not lamellae number. J. Neurol. Sci. 1990, 98:107.